Man Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.2M Buy
1,476,922
+672,628
+84% +$37M 0.15% 129
2025
Q1
$56.9M Buy
804,294
+301,659
+60% +$21.3M 0.14% 141
2024
Q4
$33M Sell
502,635
-113,443
-18% -$7.46M 0.09% 233
2024
Q3
$43.3M Buy
616,078
+485,670
+372% +$34.1M 0.11% 212
2024
Q2
$10.7M Buy
130,408
+45,362
+53% +$3.73M 0.03% 642
2024
Q1
$7.43M Buy
85,046
+20,703
+32% +$1.81M 0.02% 783
2023
Q4
$6.2M Buy
+64,343
New +$6.2M 0.02% 816
2023
Q3
Sell
-279,334
Closed -$24.2M 694
2023
Q2
$24.2M Buy
+279,334
New +$24.2M 0.07% 329
2023
Q1
Sell
-663,969
Closed -$68.7M 81
2022
Q4
$68.7M Buy
663,969
+115,421
+21% +$11.9M 0.25% 88
2022
Q3
$46.5M Buy
+548,548
New +$46.5M 0.22% 110
2022
Q2
Sell
-64,777
Closed -$5M 401
2022
Q1
$5M Buy
+64,777
New +$5M 0.02% 893
2021
Q4
Sell
-10,764
Closed -$832K 1884
2021
Q3
$832K Sell
10,764
-5,515
-34% -$426K ﹤0.01% 1381
2021
Q2
$1.36M Sell
16,279
-47,504
-74% -$3.97M ﹤0.01% 1315
2021
Q1
$4.82M Buy
63,783
+17,868
+39% +$1.35M 0.02% 706
2020
Q4
$4.03M Buy
45,915
+656
+1% +$57.5K 0.02% 920
2020
Q3
$3.44M Sell
45,259
-48,177
-52% -$3.67M 0.01% 990
2020
Q2
$11.5M Buy
93,436
+64,813
+226% +$7.99M 0.06% 316
2020
Q1
$2.42M Sell
28,623
-13,677
-32% -$1.16M 0.02% 807
2019
Q4
$3.58M Buy
42,300
+3,460
+9% +$293K 0.01% 1115
2019
Q3
$2.62M Buy
38,840
+1,522
+4% +$103K 0.01% 1150
2019
Q2
$3.2M Sell
37,318
-6,037
-14% -$517K 0.01% 1132
2019
Q1
$3.85M Sell
43,355
-31,711
-42% -$2.82M 0.01% 1042
2018
Q4
$6.39M Sell
75,066
-14,116
-16% -$1.2M 0.03% 634
2018
Q3
$8.65M Buy
89,182
+63,109
+242% +$6.12M 0.03% 692
2018
Q2
$2.46M Sell
26,073
-91,113
-78% -$8.58M 0.01% 1265
2018
Q1
$9.5M Buy
+117,186
New +$9.5M 0.04% 512